California Public Employees Retirement System raised its stake in LivaNova PLC (NASDAQ:LIVN) by 1.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 104,632 shares of the company’s stock after buying an additional 1,078 shares during the period. California Public Employees Retirement System owned approximately 0.22% of LivaNova worth $6,928,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. Strs Ohio boosted its stake in shares of LivaNova by 66.7% during the 4th quarter. Strs Ohio now owns 2,500 shares of the company’s stock worth $165,000 after acquiring an additional 1,000 shares in the last quarter. Todd Asset Management LLC boosted its position in shares of LivaNova by 6.9% in the 3rd quarter. Todd Asset Management LLC now owns 4,449 shares of the company’s stock valued at $201,000 after purchasing an additional 289 shares during the period. Nisa Investment Advisors LLC boosted its position in shares of LivaNova by 39.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 4,605 shares of the company’s stock valued at $208,000 after purchasing an additional 1,300 shares during the period. Pinnacle Associates Ltd. purchased a new position in LivaNova in the 4th quarter worth about $218,000. Finally, Poplar Forest Capital LLC acquired a new stake in LivaNova during the 4th quarter worth about $230,000. Institutional investors own 89.10% of the company’s stock.
A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of LivaNova from a “sell” rating to a “hold” rating in a report on Monday, February 15th. Piper Sandler upped their price target on LivaNova from $70.00 to $73.00 and gave the company an “overweight” rating in a research report on Tuesday, January 12th. Finally, Needham & Company LLC downgraded LivaNova from a “buy” rating to a “hold” rating in a research note on Tuesday, January 5th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $66.71.
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CVÂ) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients.
Further Reading: How to start trading in the forex market?
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.